연구동향 분석

Pepsin and Laryngeal and Hypopharyngeal Carcinomas

Cheng-Yi Yin Sha-Sha Zhang Jiang-Tao Zhong Shui-Hong Zhou 2021년

논문상세정보
인용/피인용
' Pepsin and Laryngeal and Hypopharyngeal Carcinomas' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • Hypopharyngeal Carcinoma
  • Keywords. Pepsin
  • Laryngeal Carcinoma
  • Laryngopharyngeal Reflux
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
8 0

0.0%

' Pepsin and Laryngeal and Hypopharyngeal Carcinomas' 의 참고문헌

  • pH stability and activity curves of pepsin with special reference to their clinical importance
    Piper DW [1965]
  • What is the evidence that gastroesophageal reflux is involved in the etiology of laryngeal cancer?
    Wilson JA [2005]
  • Validity and reliability of the reflux symptom score
    Lechien JR [2020]
  • Validity and reliability of the reflux sign assessment
    Lechien JR [2020]
  • The value of a liquid alginate suspension (Gaviscon Advance) in the management of laryngopharyngeal reflux
  • The role of an alginate suspension on pepsin and bile acids: key aggressors in the gastric refluxate: does this have implications for the treatment of gastro-oesophageal reflux disease?
    Strugala V [2009]
  • The role of acid and alkaline reflux in laryngeal squamous cell carcinoma
    Galli J [2002]
  • The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury
    Koufman JA [1991]
  • The diagnostic value of pepsin detection in saliva for gastro-esophageal reflux disease: a preliminary study from China
    Du X [2017]
  • The carbonic anhydrases: widening perspectives on their evolution, expression and function
    Tashian RE [1989]
  • The cadherin-catenin complex in laryngeal squamous cell carcinoma
  • The Role of Transnasal Esophagoscopy in ENT Office: A Prospective, Multicenter Study in Korea
    정은재 [2014]
  • The Role of Laryngopharyngeal Reflux as a Risk Factor in Laryngeal Cancer: A Preliminary Report
    태경 [2011]
  • Structure, refinement, and function of carbonic anhydrase isozymes: refinement of human carbonic anhydrase I
    Kannan KK [1984]
  • Sensitive pepsin immunoassay for detection of laryngopharyngeal reflux
    Knight J [2005]
  • Salivary pepsin lacks sensitivity as a diagnostic tool to evaluate extraesophageal reflux disease
    Dy F [2016]
  • Role of esophageal pH recording in management of chronic laryngitis: an overview
    Hanson DG [2000]
  • Role of PH monitoring in laryngopharyngeal reflux patients with voice disorders
    Maldhure S [2016]
  • Review: head and neck squamous cell carcinoma in sub-Saharan Africa
    Faggons CE [2015]
  • Review article: acidity and volume of the refluxate in the genesis of gastro-oesophageal reflux disease symptoms
    Sifrim D [2007]
  • Relationship between reflux and laryngeal cancer
  • Reflux-associated laryngitis and laryngopharyngeal reflux: a gastroenterologist’s point of view
    Hammer HF [2009]
  • Reflux revisited: advancing the role of pepsin
    Bardhan KD [2012]
  • Reevaluation of gastroesophageal reflux disease as a risk factor for laryngeal cancer
    Francis DO [2011]
  • Receptor-mediated uptake of pepsin by laryngeal epithelial cells
    Johnston N [2007]
  • Rationale for targeting pepsin in the treatment of reflux disease
    Johnston N [2010]
  • Rapid salivary pepsin test: blinded assessment of test performance in gastroesophageal reflux disease
  • Randomised clinical trial: alginate (Gaviscon Advance) vs. placebo as add-on therapy in reflux patients with inadequate response to a once daily proton pump inhibitor
    Reimer C [2016]
  • Proton-pump inhibitor overuse: a cautionary tale in misguided benefit
    Nath K [2019]
  • Proton transfer in catalysis and the role of proton shuttles in carbonic anhydrase
    Mikulski RL [2010]
  • Proton pump inhibitors do not reduce the risk of esophageal adenocarcinoma in patients with Barrett’s esophagus: a systematic review and meta-analysis
    Hu Q [2017]
  • Proton pump inhibitor use may not prevent high-grade dysplasia and oesophageal adenocarcinoma in Barrett’s oesophagus: a nationwide study of 9883 patients
  • Protein-protein interactions in the molecular chaperone network
    Freilich R [2018]
  • Protein folding while chaperone bound is dependent on weak interactions
    Wu K [2019]
  • Prevalence of gastroesophageal reflux disease and proton pump inhibitor-refractory symptoms
    Delshad SD [2020]
  • Prevalence and clinical predictors of LPR among patients diagnosed with GERD according to the reflux symptom index questionnaire
    Mosli M [2018]
  • Pepsin: biomarker, mediator, and therapeutic target for reflux and aspiration
    Johnston N [2018]
  • Pepsin triggers neutrophil migration across acid damaged lung epithelium
    Hurley BP [2019]
  • Pepsin promotes proliferation of laryngeal and pharyngeal epithelial cells
    Johnston N [2012]
  • Pepsin promotes laryngopharyngeal neoplasia by modulating signaling pathways to induce cell proliferation
    Niu K [2020]
  • Pepsin promotes IL-8 signaling-induced epithelial-mesenchymal transition in laryngeal carcinoma
    Tan JJ [2019]
  • Pepsin in saliva for the diagnosis of gastro-oesophageal reflux disease
    Hayat JO [2015]
  • Pepsin in saliva as a diagnostic marker for gastroesophageal reflux disease: a meta-analysis
    Guo Z [2018]
  • Pepsin in saliva as a biomarker for oropharyngeal reflux compared with 24-hour esophageal impedance/pH monitoring in pediatric patients
  • Pepsin as a causal agent of inflammation during nonacidic reflux
    Samuels TL [2009]
  • Pepsin and carbonic anhydrase isoenzyme III as diagnostic markers for laryngopharyngeal reflux disease
    Johnston N [2004]
  • Pepsin and bile acids in saliva in patients with laryngopharyngeal reflux: a prospective comparative study
  • Paroxysmal laryngospasm: a typical but underrecognized supraesophageal manifestation of gastroesophageal reflux?
    Poelmans J [2004]
  • Optimization of saliva collection and immunochromatographic detection of salivary pepsin for point-of-care testing of laryngopharyngeal reflux
    Lee YJ [2020]
  • Optimal timing of saliva collection to detect pepsin in patients with laryngopharyngeal reflux
    Na SY [2016]
  • Objective detection of esophagopharyngeal reflux in patients with hoarseness and endoscopic signs of laryngeal inflammation
    Hayat JO [2014]
  • No association between gastroesophageal reflux and cancers of the larynx and pharynx
    Nilsson M [2005]
  • Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux
    Samuels TL [2008]
  • MicroRNA‑143‑3p suppresses cell growth and invasion in laryngeal squamous cell carcinoma via targeting the k‑Ras/Raf/MEK/ERK signaling pathway
    Zhang F [2019]
  • Membrane-anchored carbonic anhydrase IV interacts with monocarboxylate transporters via their chaperones CD147 and GP70
  • Long-term survival in head and neck cancer: impact of site, stage, smoking, and human papillomavirus status
    Du E [2019]
  • Locally advanced hypopharyngeal and laryngeal cancer: influence of HPV status
    Bates JE [2019]
  • Local synthesis of pepsin in Barrett’s esophagus and the role of pepsin in esophageal adenocarcinoma
    Samuels T [2015]
  • Laryngopharyngeal reflux: the value of otolaryngology examination
    Belafsky PC [2008]
  • Laryngopharyngeal reflux is different from classic gastroesophageal reflux disease
    Koufman JA [2002]
  • Laryngopharyngeal reflux and voice disorders: a multifactorial model of etiology and pathophysiology
    Lechien JR [2017]
  • Laryngeal granuloma in experimental rats with gastroesophageal reflux disease and mechanically injured vocal cord mucosa
    Shimazu R [2014]
  • Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial
    El-Serag HB [2001]
  • Is there any association between esophagogastric endoscopic findings and laryngeal cancer?
  • Is laryngopharyngeal reflux an important risk factor in the development of laryngeal carcinoma?
    Ozlugedik S [2006]
  • Insights into the role of reactive sulfhydryl groups of Carbonic Anhydrase III and VII during oxidative damage
    Monti DM [2017]
  • Influence of molecular and chemical chaperones on protein folding
    Welch WJ [1996]
  • Increased risk of larynx cancer in patients with gastroesophageal reflux disease from a national sample cohort
    Kim SY [2019]
  • Increased pharyngeal reflux in patients treated for laryngeal cancer: a pilot study
    LeBlanc B [2015]
  • In vitro model for gastroduodenal reflux-induced nuclear factor-kappaB activation and its role in hypopharyngeal carcinogenesis
    Sasaki CT [2016]
  • Impact of macromolecular crowding on structure and properties of pepsin and trypsin
    Gtari W [2017]
  • Impact of gastro-esophageal reflux on mucin mRNA expression in the esophageal mucosa
    Van Roon AH [2008]
  • Immunohistochemical detection of pepsin in laryngeal mucosa for diagnosing laryngopharyngeal reflux
    Jiang A [2011]
  • Hypopharyngeal pepsin and Sep70 as diagnostic markers of laryngopharyngeal reflux: preliminary study
    Komatsu Y [2015]
  • Hypopharyngeal acid exposure: an independent risk factor for laryngeal cancer?
    Geterud A [2003]
  • Human papillomavirus in laryngeal and hypopharyngeal lymphoepithelial carcinoma
    Acuna G [2019]
  • Higher levels of total pepsin and bile acids in the saliva as a possible risk factor for early laryngeal cancer
  • High incidence of laryngopharyngeal reflux in patients with head and neck cancer
    Copper MP [2000]
  • Heterotopic gastric mucosa (inlet patch) in a patient with laryngopharyngeal reflux (LPR) and laryngeal carcinoma: a case report and review of literature
    Basseri B [2009]
  • Head and neck squamous cell carcinoma: update on epidemiology, diagnosis, and treatment
    Marur S [2016]
  • HPV-positive squamous cell carcinoma of the larynx, oral cavity, and hypopharynx: clinicopathologic characterization with recognition of a novel warty variant
    Rooper LM [2020]
  • Gaviscon® Advance alone versus co-prescription of Gaviscon® Advance and proton pump inhibitors in the treatment of laryngopharyngeal reflux
    Wilkie MD [2018]
  • Gastroesophageal reflux disease symptom severity, proton pump inhibitor use, and esophageal carcinogenesis
    Nason KS [2011]
  • Gastroesophageal reflux disease is a risk factor for laryngeal and pharyngeal cancer
    El-Serag HB [2001]
  • Gastroesophageal reflux disease and odds of head and neck squamous cell carcinoma in North Carolina
    Busch EL [2016]
  • Gastroesophageal reflux and laryngeal cancer: causation or association? A critical review
    Qadeer MA [2006]
  • Gastroesophageal reflux and carcinoma of larynx or pharynx: a meta-analysis
    Zhang D [2014]
  • Gastroesophageal and laryngopharyngeal reflux associated with laryngeal malignancy: a systematic review and meta-analysis
    Parsel SM [2019]
  • Gastric reflux is an independent risk factor for laryngopharyngeal carcinoma
    Langevin SM [2013]
  • Evaluation of omeprazole in the treatment of reflux laryngitis: a prospective, placebo-controlled, randomized, double-blind study
    Noordzij JP [2001]
  • Evaluation and management of laryngopharyngeal reflux disease: state of the art review
    Lechien JR [2019]
  • Evaluation and management of laryngopharyngeal reflux
    Ford CN [2005]
  • Esophageal pepsin and proton pump synthesis in barrett’s esophagus and esophageal adenocarcinoma
    Samuels TL [2019]
  • Epidemiological profile of head and neck cancer patients in Western Uttar Pradesh and analysis of distributions of risk factors in relation to site of tumor
    Alam MS [2017]
  • Endoscopic, endoluminal fundoplication for gastroesophageal reflux disease: initial experience and lessons learned
  • Effect of pepsin on laryngeal stress protein (Sep70, Sep53, and Hsp70) response: role in laryngopharyngeal reflux disease
    Johnston N [2006]
  • Effect of pantoprazole on the course of reflux-associated laryngitis: a placebo-controlled double-blind crossover study
    Eherer AJ [2003]
  • Effect of high dose omeprazole on gastric pepsin secretion and serum pepsinogen levels in man
    Ten Kate RW [1988]
  • Effect of cigarette smoking on gastropharyngeal and gastroesophageal reflux
    Smit CF [2001]
  • Effect of acid suppression on molecular predictors for esophageal cancer
  • E-cadherin but not beta-catenin expression is decreased in laryngeal biopsies from patients with laryngopharyngeal reflux
    Reichel O [2008]
  • Does gene expression in laryngeal subsites differ between patients with laryngopharyngeal reflux and controls?
    Wood JM [2018]
  • Detection of porcine pepsin in model cheese using polyclonal antibody-based ELISA
  • Detection of laryngeal carcinoma in the U.S. elderly population with gastroesophageal reflux disease
    Riley CA [2019]
  • Current theories for the development of nonsmoking and nondrinking laryngeal carcinoma
    Wight R [2003]
  • Current indications for transnasal esophagoscopy: an american broncho-esophagological association survey
    Best AR [2018]
  • Curcumin and anthocyanin inhibit pepsin-mediated cell damage and carcinogenic changes in airway epithelial cells
    Samuels TL [2013]
  • Comparison of the structural characteristics of native collagen fibrils derived from bovine tendons using two different methods: modified acid-solubilized and pepsin-aided extraction
    Ju H [2020]
  • Comparison of impedance and pepsin detection in the laryngeal mucosa to determine impedance values that indicate pathological laryngopharyngeal reflux
    Formanek M [2017]
  • Characteristics of symptomatic reflux episodes on acid suppressive therapy
    Tutuian R [2008]
  • Cell biology of laryngeal epithelial defenses in health and disease: further studies
    Johnston N [2003]
  • Cadherins in cancer: implications for invasion and metastasis
    Takeichi M [1993]
  • CDH2 and CDH11 act as regulators of stem cell fate decisions
    Alimperti S [2015]
  • Biliary tumorigenic effect on hypopharyngeal cells is significantly enhanced by pH reduction
    Doukas SG [2019]
  • Biliary reflux as a causal factor in hypopharyngeal carcinoma: new clinical evidence and implications
    Sasaki CT [2019]
  • Association of gastroesophageal reflux disease and laryngeal cancer
    Anis MM [2018]
  • An analysis of persistent symptoms in acid-suppressed patients undergoing impedance-pH monitoring
    Sharma N [2008]
  • Ambulatory pH monitoring methodology
    Postma GN [2000]
  • Abilities of oropharyngeal pH tests and salivary pepsin analysis to discriminate between asymptomatic volunteers and subjects with symptoms of laryngeal irritation
    Yadlapati R [2016]
  • ATP4a is required for development and function of the Xenopus mucociliary epidermis: a potential model to study proton pump inhibitor-associated pneumonia
    Walentek P [2015]
  • A pilot study of Helicobacter pylori infection and risk of laryngopharyngeal cancer